Microglia are resident hematopoietic cells that play important roles in the damaged or degenerating adult nervous system. Microglia are involved in neuropathogenesis of various diseases. Microglia are also essential for neuroprotection and comprise an essential component of the neural stem cell niche. The activation of microglia is an important phenomenon associated with several neurological disorders that arise from infections to developmental abnormalities and behavioral pathologies. Noonan syndrome (NS) is associated with mutations in the PTPN11 gene and also accounts for mental retardation in children. Interestingly, in mouse models of NS, mutations in the PTPN11 gene resulted in dysregulation of neural progenitors. The present study describes the activation of microglia in the NS mouse model, which results in an inflammatory phenotype with expression of IL-1b and defective phagocytosis. To test whether microglia from NS mice are important for neural precursor maintenance or self-renewal, embryonic neural precursors from the cortex of WT mice were cultured. Microglia from NS and WT mice were then added to cortical precursor cells which showed that microglia from NS mice inhibited astrogenesis. Together, these results demonstrate that microglia can dysregulate neural precursor development in NS, and suggest that alterations in microglial number as a consequence of genetic or pathological events may perturb neural development by directly affecting embryonic neural precursors.
Introduction
The resident tissue macrophages in the central nervous system (CNS), microglia and perivascular macrophages, are highly specialized cells that influence their local microenvironment. Microglia rapidly change their morphology and their expression of secreted and membrane-bound factors in response to changes in homeostasis and insults to the brain [1] . Inflammation alters microglial phenotype, which is evident on histological analysis-a downregulated phenotype with long processes conferring a ramified morphology and an activated phenotype characterized by shortened and extensively branched processes and hypertrophy of the cell body [2] . However, cells in the non-activated state are not 'resting' but rather are in a constant state of surveillance [3] .
There is interesting and novel evidence that microglia play a crucial role in monitoring and maintaining synapses in the uninjured brain [4] as well as synaptic pruning [5] . These functions are complementary to the traditional role of phagocytosis that microglia perform and serves to highlight the important biology of these cells. However, microglia also mediate several pathogenic processes and particularly in the developing brain, where microglia become activated following maternal infections, this can lead to profound neurodevelopmental disorders. In the fetal brain from mothers diagnosed with schizophrenia, microglia are in an activated state [6, 7] . Interestingly, in Down's syndrome, microglia are ramified and more numerous compared to normal fetal CNS [8] . Activated and inflammatory microglia express enhanced levels of MHC class I and II proteins conferring on these cells the ability to recognize and respond to antigens. In the adult CNS, microglia play a key role in neuroinflammation [9] . Interestingly, microglia are also found adjacent to adult neural stem cells [10] suggesting that these cells might alter the cellular environment of neural precursors.
Indeed, microglia clear dying neurons, as well as promote programmed cell death of Purkinje neurons [11] . While it is known that activated microglia affect neuronal differentiation and several other functions during maternal infections [12] , there is very little evidence for genetic mutations involving microglia affecting neurodevelopmental disorders.
The present study investigated the role of microglia in the development of a neurological disorder called Noonan syndrome
(NS). Germline mutations in PTPN11 (SHP-2)
cause the autosomal dominant disorder, NS in humans, characterized by short stature, facial dysmorphia, hypertelorism and cardiac defects [13] . Shp-2 is a nonreceptor protein tyrosine phosphatase (PTP) which is required for full activation of the Ras/ERK pathway and for multiple receptor-evoked functions, including cell proliferation, differentiation and migration [14] . The molecular, cellular and developmental effects of disease-associated SHP-2 mutations are slowly being unraveled. Previously, a knock-in mice expressing the NS-associated 
experimental procedures

Animals
Generation of mice with D61G mutation has been previously described [15] , and these mice were maintained and genotyped as previously described [15] . Postnatal (P2) Fragile-X mice were obtained from Dr Min Zhuo [17] . Timepregnant CD1 mice were obtained from Charles River Laboratories. All animal use was approved by the Hospital for Sick Children Animal Care
Committee, and use was in accordance with the Canadian Council on Animal Care guidelines.
Cell culture and reagents
Cortical precursor cells were cultured as previously described [16, [18] [19] [20] . amplified product size-448 bp).
Immunocytochemistry
Immunocytochemistry of cultured cells and tissue sections was performed as described [16, 19, 20] . (Figure 1) . Specifically, the expression of Iba-1, a microglial marker, in P2
brain sections was examined which revealed that Iba-1-positive microglia were scattered throughout the hippocampus ( Figure 1A ,B,C) and cortex ( Figure 1E ,F,G). However, the number of microglia was significantly increased in the hippocampus of NS mouse compared to that of the WT ( Figure 1D ). Indeed, earlier during development when embryonic day 18.5 (E18.5) embryos were examined, there was again a significant increase in the hippocampus ( Figure 1I ) but this increase in microglia number in the NS mouse brain was not significant in the cortex at E18.5 ( Figure 1H ) and later on in the adult hippocampus ( Figure 1J ). in WT vs 4.8% in NS. Secondly, cortical tissues from E14.5 embryonic mice were removed and cortical precursor cultures were performed as described previously [23] . Specifically, microglia within E14.5 cortical precursor cultures were immunostained with the Iba-1 antibody which revealed a significant increase in the number of microglia within cortical tissues ( Figure 2B ).
Having determined that microglia numbers were elevated in mouse brain and cell cultures, microglia was then isolated using the Percoll gradient protocol as described previously [23] . Microglia were cultured overnight, and then the cells were transfected with D61G or GFP plasmids. This was followed by immunostaining the cultures for Ki-67, a marker of cell proliferation ( Figure 2C ). Complementing this approach, microglia were also infected with adenovirus expressing D61G or GFP at multiplicity of infection (MOI) of 1:5 ( Figure 2D ) and of 1:200 ( Figure 2E ). These experiments showed that D61G induced proliferation in pure microglia cultures. To address whether cortical precursor differentiation was affected, cortical progenitors from WT and NS mouse were cultured as described previously [23] .
Cells were immunostained for βIII-tubulin to determine neurogenesis and GFAP to determine 
Microglia in NS mouse brain are inflammatory and defective in phagocytosis
Microglia proliferation is a key response to damage in the brain [24] . Cytokines such as IL-1b and TNF-a which are produced in a variety of CNS pathologies, have numerous functions including stimulation of microglia proliferation [25] . Activated microglia express several molecules and in particular, a robust immune response requires expression of pattern recognition receptors such as CD14, a surface molecule of monocytoid cells which is up-regulated after monocyte stimulation and is involved in cellular activation [26] .
In order to determine whether microglia in NS mouse is activated and inflammatory, immunohistochemistry was performed which revealed a significant number of CD14-positive inflammatory microglia/macrophages in the cortex of NS ( Figure 3B ) mouse compared to that of WT ( Figure 3A) . In order to examine the cytokine gene expression pattern involved in 
Increased microglia perturb cortical precursor development
Increased microglial numbers in the adult brain have been associated with many biological effects, both beneficial and pathological [28] . In the embryonic brain, increased microglial numbers might occur in response to pathological conditions such as maternal infections [29, 30] . Since a previous study has shown that endogenous microglia can regulate neural precursor biology [23] , it became imperative to ask whether an increase in the proportion of activated and inflammatory microglia might adversely affect cortical precursors. To do this, embryonic microglia were isolated from WT or NS (P2) mice by FACS and then added to E12-E13 cortical precursors from CD1 mice, until the relative microglial density was 0.6%.
Immunostaining and subsequently quantifying the number of Ki-67+ cells in these cultures at 2 days demonstrated that the activated and inflammatory microglia from NS mouse had no effect on cell proliferation compared to that of the WT ( Figure 4A ). Astrogenesis was examined in these cultures by immunostaining for GFAP at 6 days, which demonstrated that activated and inflammatory microglia from NS mouse decreased astrogenesis ( Figure 4B ). In parallel experiments, control microglia from CD1 mice were added to cortical precursors which showed an increase in astrogenesis, as expected [23] (Figure 4C ). Interestingly, microglia from a mouse with Fragile-X, a different neurodevelopmental disorder, also induced astrogenesis ( Figure 4D ). These results suggest that microglia in NS mouse brain exhibit a specific pathological phenotype that affects cortical progenitor development, particularly dysregulating astrogenesis, and that the effect of D61G is dependent on the phenotype of the cells being studied. Microglia play a key role in phagocytosis in the embryonic brain [31] , and also directly regulate programmed cell death in neurons [11] . Exogenous microglia and/or their conditioned medium have been shown to induce astrogenesis [32, 33] , in addition to other effects including neuronal migration and differentiation [12, 34] . Thus, microglia in the developing brain fulfill multiple roles [35] , and, like other non-neural cells within the embryonic neural tissue [10] , play an important role (s) in regulating the neural precursor environment.
discussion
Microglia regulate neural precursor development due to their ability to synthesize and secrete several cytokines and growth factors, including but not limited to, Immunocytochemical analysis of coronal sections of postnatal day2 WT (A) and NS (B) brains labeled for the microglia marker Iba-1 (in red) and the nuclear stain Hoechst33258, shows an increase in the number of CD14+ cells (arrows) in the cortex of NS mouse compared to WT (x40 mag.). RAW macrophage cell line was infected with Ad-D61G (C) or Ad-GFP (D). RT-PCR was performed to detect IL-1b gene expression in GFP-or D61G-expressing RAW macrophages which showed increased IL-1b expression in Ad-D61G macrophages compared to Ad-GFP macrophages even in the absence of bacterial LPS, a known activator of macrophages (E, top panel). RT-PCR of cortex tissue (E, middle panel) and whole brain tissue (E, bottom panel) also showed a significant increase in the expression of IL-1b in NS mouse compared to WT. (F) A phagocytosis assay using time-lapse imaging was performed to determine the ability of microglia to ingest yeast particles. Results show that microglia expressing GFP showed a number of yeast particles within the cell body (F, top, white arrow) whereas microglia expressing D61G did not ingest yeast particles (F, bottom).
BDNF [36] , FGF [37] , and IGF [38] , all of which are known to regulate cortical precursor biology [39] . Activated microglia might block astrogenesis in the developing brain, either due to the inflammatory response or the lack of specific growth factors associated with astrogenesis. Indeed, NS mice exhibited a dysregulated growth factor expression profile (data not shown).
Interestingly, a transgenic mouse model exhibiting sustained expression of IL-1b in the hippocampus showed hypertrophied astrocytes and activated microglia along with deficits in spatial memory [40] . This suggests that in NS, cytokines and growth factors might be acting in synergy to block astrogenesis, which corroborates the finding that the D61G mutation in a key signaling protein, SHP-2, instruct multipotent precursor cells to generate one cell type versus another [16] . The data presented here, together with previous work, demonstrating that exogenous microglia (or their conditioned medium) added to developing neural precursors [12, 33, 34] can induce astrogenesis [23] , suggested that embryonic perturbations which enhance microglial number or activation state will alter neural precursor development. The increase in microglial proliferation due to D61G mutation is similar to the increase in the number of cytokine-independent myeloid colonies when D61G was expressed in murine bone-marrow cells [41] . Indeed, the NS mouse model is a good example of a neurological disorder where microglia are inflammatory on account of a genetic mutation. In fact, the NS mouse shows deficits in hippocampus-dependent learning (Araki T, personal communication).
In addition to inducing an inflammatory phenotype in microglia, D61G expression also dysregulated growth factor expression (data not shown) and abrogated phagocytic functions.
Importantly, reduced astrogenesis observed in response to inflammatory microglia is similar to the phenotype shown in NS mouse which exhibits reduced astrogenesis at the expense of increased neurogenesis [16] . 
